New Data Reinforces Benefits of Spiolto® Respimat® in Improving Patient Outcomes

  • Data supports the efficacy and safety profile of Spiolto®Respimat®1

  • Results from one study emphasise patient satisfaction and ease-of-use with Respimat® inhaler2

  • Two formative usability studies underscore the patient-centric design and enhanced usability of Respimat® re-usable inhaler3

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Boehringer Ingelheim

Improving the health of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.